X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-17 | UPXI | Salkind Gene | Dir, 10% | P - Purchase | $2.28 | +241,229 | 365,127 | +195% | +$550,002 | |||||
2024-01-05 | COEP | Salkind Gene | Dir | P - Purchase | $0.69 | +11,600 | 316,740 | +4% | +$8,004 | ||||||
| M | 2023-08-25 | COEP | Salkind Gene | Dir | P - Purchase | $0.92 | +32,644 | 254,092 | +15% | +$30,107 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |